VYGR 8-K 2026-01-08

Voyager Therapeutics, Inc. (VYGR) 8-K dated 2026-01-08 — accession 0001104659-26-001955. This URL is the filing, not the VYGR hub.

Voyager Therapeutics, Inc. (VYGR) is a biotechnology company listed on NASDAQ.

Voyager Therapeutics, Inc. filed a 8-K on 2026-01-08. Accession 0001104659-26-001955.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VYGR revenue for 2025-12-31 was $40.4M. Net income was -$119.7M. Revenue was down 49.5% from 2024-12-31 to 2025-12-31. VYGR currently screens at market cap $225.4M.

Not investment advice. The VYGR SEC hub lists recent forms. The stock page is the research view.